Key genetic variants, such as PNPLA3 p.I148M and TM6SF2 p.E167K, contribute to TG accumulation in the liver [159,164], increasing the risk of MASH, fibrosis, cirrhosis, and HCC [49]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.